Good Laboratory Practice (GLP)

ProPharma ensures global GLP and lab compliance with QMS development, inspection readiness, remediation, and quality oversight.

GLP Consulting Services

ProPharma's Quality & Compliance team offers Sponsors, laboratories, and CROs a full range of global good laboratory practice and compliance support services for Clinical Study, Pharmacy, CMO, CDMO, CROs, and third-party testing labs. We assist in achieving and maintaining full compliance with GLP, GCLP, OECD, CAP, and CLIA regulations. Our consultants combine deep regulatory knowledge, operational experience, and a global perspective to ensure your non-clinical, clinical development, and bio/analytical programs meet international standards to support compliance aspects such as:

smiling-woman-high-fiving-coworker-as-983431523-650x425

Illustration of ProPharma's Good Laboratory Practice (GLP) services overview

 

Gloved hand working with test tubes and vials in a lab

Nonclinical GLP Laboratory  Compliance Services

We offer comprehensive Good Laboratory Practice support for facilities, sponsors, and testing labs conducting regulated nonclinical safety and toxicology studies.

Our GLP services include:

  • GLP Facility & Study Conduct Audits
  • Bioanalytical and Histopathology Compliance Assessments
  • Test Article and Specimen Handling Reviews
  • Toxicology Study Design and In-Life Phase Oversight (In-Vivo / In-Vitro)
  • Data Integrity Audits (21 CFR Part 11, OECD, ALCOA+)
  • Regulatory Inspection Readiness (FDA, EMA, MHRA, PMDA)

Enabling IND/CTA/NDA Laboratory & Testing Compliance

We support the transition from discovery through Investigational New Drug (IND) and Clinical Trial Application (CTA) to New Drug Application (NDA) testing with compliance audits, quality management system support, data integrity monitoring, and QA oversight services.

Our services include:

  • GLP Oversight of IND/CTA-Supporting Studies
  • CRO and Laboratory Qualification Audits
  • Electronic Lab System Assessments (LIMS, ELN, CDS)
  • Sponsor Oversight SOPs and GLP Quality Systems
  • Regulatory Submission Readiness (IND, CTA)
Woman focused on injecting test tube

GCLP, CAP & CLIA Compliance for Clinical Trial Laboratory

Ensure your clinical trial testing laboratories meet GCLP, CLIA, and CAP requirements to support compliant and inspection-ready operations.

GCLP Compliance Services

For central labs, specialty labs, and sponsor-oversight programs: 

  • GCLP Audits and Mock Inspections
  • SOP Development for Sample Handling and Bioanalytical Testing
  • Chain of Custody and Logistics Reviews
  • Laboratory Vendor Qualification and Monitoring

CAP/CLIA Compliance Services (U.S. Labs)

For clinical labs performing testing under U.S. regulations: 

  • CLIA Certification Consulting and Gap Assessments
  • CAP Accreditation Preparation and Inspection Readiness
  • QMS Implementation and Lab Process Optimization
  • Response Planning for CAP/CLIA Deficiencies
  • Audit and Validation of Laboratory Information Systems (LIS)

Clinical and CMC Transition Support

We support clinical development teams as they interface with data from nonclinical and early CMC programs.

Services include:

  • GLP-to-GCP Data Traceability Audits
  • Oversight of Bioanalytical Labs Supporting Clinical Trials
  • Companion Diagnostic and Biomarker Lab Compliance Reviews
  • Technical Transfer
    and Method Transfer Compliance Reviews
  • GCLP/CMC Consulting for Clinical Sample Analysis

Analytical Testing Compliance for Sponsors

We help commercial and manufacturing organizations manage GLP-related functions within GxP environments.

Services include: 

  • Non-GMP Laboratory Phase Appropriate Best Scientific Practices Compliance
  • GLP Audit of R&D Labs within GMP Sites
  • Analytical Method Transfer Compliance Support
  • Stability and Shelf-Life Study Review

General Laboratory Compliance Services

Whether you're preparing for an inspection or establishing your first QA system, our global consultants can help.

  • Global Regulatory Intelligence (FDA, EMA, MHRA, OECD, WHO)
  • SOP Development & GLP/GCLP Policy Creation
  • Staff Training (GLP, GCLP, CAP, CLIA, Data Integrity)
  • CAPA Planning
    and Remediation Project Management
  • Mock Inspections and Enforcement Readiness Support
  • Quality System Development and Staff Augmentation

Partner with ProPharma for Good Laboratory Practice Services

Partner with us for expert laboratory compliance and quality solutions. Contact ProPharma today to learn how we can support your organization's laboratory Quality Assurance needs.

News & Insights

Good Machine Learning Practice (GMLP)

November 17, 2025

Good Machine Learning Practice (GMLP)

Ensuring AI/ML in life sciences meets regulatory standards with ProPharma's GMLP framework, blending innovation with compliance for reliable, safe, and effective digital transformation.

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

Good Machine Learning Practice (GMLP)

November 17, 2025

Good Machine Learning Practice (GMLP)

Ensuring AI/ML in life sciences meets regulatory standards with ProPharma's GMLP framework, blending innovation with compliance for reliable, safe, and effective digital transformation.

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow